Open AccessA New Phase II Agent Holds Promise for First FDA Approved Therapy for Treatment of Acute Vaso-Occlusive Pain Events in SCD
Author(s) -
Michael R. DeBaun
Publication year - 2017
Publication title -
the hematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v14.2.7115
Subject(s) - medicine , acute pain , intensive care medicine , pharmacology , anesthesia